speb/financial-data huggingface dataset:
IBC.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 1228000.00
IBC.AX balance_sheet (annual, 2024-06-30) — Trading Securities: 35506000.00
IBC.AX income_statement (annual, 2025-06-30) — +Total Revenue: 3903000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Accounts Payable: 962000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 962000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Accounts Receivable: 211000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 211000.00
IBC.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 105885494.00
IBC.AX income_statement (annual, 2025-06-30) — Basic EPS: 0.03
IBC.AX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 907000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Capital Stock: 58055000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 58055000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 4225000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 4225000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 4225000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 4225000.00
IBC.AX cash_flow (annual, 2025-06-30) — Cash Dividends Paid: -2597000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Cash Financial: 4225000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 4225000.00
IBC.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3395000.00
IBC.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
IBC.AX cash_flow (annual, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: 6713000.00
IBC.AX cash_flow (annual, 2025-06-30) — Changes In Cash: 3318000.00
IBC.AX cash_flow (annual, 2025-06-30) — Classesof Cash Payments: -455000.00
IBC.AX cash_flow (annual, 2025-06-30) — Classesof Cash Receiptsfrom Operating Activities: 7168000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Common Stock: 58055000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 58055000.00
IBC.AX cash_flow (annual, 2025-06-30) — Common Stock Dividend Paid: -2597000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 59746000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 59746000.00
IBC.AX cash_flow (annual, 2025-06-30) — Common Stock Payments: -798000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 733000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 733000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Current Deferred Taxes Liabilities: 733000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Taxes Liabilities: 733000.00
IBC.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 105885494.00
IBC.AX income_statement (annual, 2025-06-30) — Diluted EPS: 0.03
IBC.AX cash_flow (annual, 2025-06-30) — End Cash Position: 4225000.00
IBC.AX cash_flow (annual, 2025-06-30) — Financing Cash Flow: -3395000.00
IBC.AX cash_flow (annual, 2025-06-30) — Free Cash Flow: 6713000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 10661000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 10661000.00
IBC.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 61000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Gross Accounts Receivable: 211000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 211000.00
IBC.AX income_statement (annual, 2025-06-30) — Interest Income: 1396000.00
IBC.AX cash_flow (annual, 2025-06-30) — Investing Cash Flow: 0.00
IBC.AX balance_sheet (annual, 2025-06-30) — Investments And Advances: 55867000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 55867000.00
IBC.AX cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: -798000.00
IBC.AX income_statement (annual, 2025-06-30) — Net Income: 3067000.00
IBC.AX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: 3067000.00
IBC.AX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: 3067000.00
IBC.AX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 3067000.00
IBC.AX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 3067000.00
IBC.AX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: 3067000.00
IBC.AX income_statement (annual, 2025-06-30) — Net Interest Income: 1396000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 59746000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 59746000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Non Current Deferred Liabilities: 95000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 95000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Non Current Deferred Taxes Liabilities: 95000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 95000.00
IBC.AX income_statement (annual, 2025-06-30) — Normalized Income: 3067000.00
IBC.AX income_statement (annual, 2025-06-30) — Operating Revenue: 3903000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 104731384.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 104731384.00
IBC.AX cash_flow (annual, 2025-06-30) — Other Cash Paymentsfrom Operating Activities: -85000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: 10661000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 10661000.00
IBC.AX income_statement (annual, 2025-06-30) — Other Non Interest Expense: 107000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Other Payable: 37000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 37000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Other Receivables: 18000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 18000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Other Short Term Investments: 23382000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 23382000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Payables: 999000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Payables: 999000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 999000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 999000.00
IBC.AX income_statement (annual, 2025-06-30) — Pretax Income: 3333000.00
IBC.AX income_statement (annual, 2025-06-30) — Professional Expense And Contract Services Expense: 402000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Receivables: 229000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 229000.00
IBC.AX cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: -798000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: -8970000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -8970000.00
IBC.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 61000.00
IBC.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 61000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Share Issued: 104731384.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 104731384.00
IBC.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 59746000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 59746000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: 59746000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 59746000.00
IBC.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IBC.AX income_statement (annual, 2025-06-30) — Tax Provision: 266000.00
IBC.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.08
IBC.AX balance_sheet (annual, 2025-06-30) — Total Assets: 61573000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 61573000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 59746000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 59746000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 1827000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1827000.00
IBC.AX balance_sheet (annual, 2025-06-30) — Trading Securities: 32485000.00
IBC.AX balance_sheet (quarterly, 2025-06-30) — Trading Securities: 32485000.00
IBCP balance_sheet (annual, 2021-12-31) — Current Accrued Expenses: 80208000.00
IBCP income_statement (annual, 2021-12-31) — Other Gand A: 13903000.00
IBCP balance_sheet (annual, 2021-12-31) — Other Receivables: 66140000.00
IBCP balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 80208000.00
IBCP balance_sheet (annual, 2021-12-31) — Receivables: 66140000.00
IBCP income_statement (annual, 2022-12-31) — +Total Revenue: 204785000.00
IBCP balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -118020000.00
IBCP income_statement (annual, 2022-12-31) — Amortization: 785000.00
IBCP income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 785000.00
IBCP income_statement (annual, 2022-12-31) — Basic Average Shares: 21117000.00
IBCP income_statement (annual, 2022-12-31) — Basic EPS: 3.00
IBCP cash_flow (annual, 2022-12-31) — Beginning Cash Position: 109473000.00
IBCP balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 60708000.00
IBCP cash_flow (annual, 2022-12-31) — Capital Expenditure: -5679000.00
IBCP cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -5679000.00
IBCP balance_sheet (annual, 2022-12-31) — Capital Stock: 320991000.00
IBCP balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 74371000.00
IBCP balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 74371000.00
IBCP cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -18565000.00
IBCP balance_sheet (annual, 2022-12-31) — Cash Financial: 70180000.00
IBCP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 294858000.00
IBCP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -424592000.00
IBCP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 94632000.00
IBCP cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 14648000.00
IBCP cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 14648000.00
IBCP cash_flow (annual, 2022-12-31) — Change In Receivables: -25843000.00
IBCP cash_flow (annual, 2022-12-31) — Change In Working Capital: -11195000.00
IBCP cash_flow (annual, 2022-12-31) — Changes In Cash: -35102000.00
IBCP balance_sheet (annual, 2022-12-31) — Common Stock: 320991000.00
IBCP cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -18565000.00
IBCP balance_sheet (annual, 2022-12-31) — Common Stock Equity: 347596000.00
IBCP cash_flow (annual, 2022-12-31) — Common Stock Issuance: 77000.00
IBCP cash_flow (annual, 2022-12-31) — Common Stock Payments: -4010000.00
IBCP balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 108023000.00
IBCP balance_sheet (annual, 2022-12-31) — Current Debt: 61000000.00
IBCP balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 61000000.00
IBCP cash_flow (annual, 2022-12-31) — Deferred Income Tax: -359000.00
IBCP cash_flow (annual, 2022-12-31) — Deferred Tax: -359000.00
IBCP cash_flow (annual, 2022-12-31) — Depreciation: 10827000.00
IBCP cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 10827000.00
IBCP income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 785000.00
IBCP cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 10827000.00
IBCP income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 785000.00
IBCP income_statement (annual, 2022-12-31) — Diluted Average Shares: 21330303.00
IBCP income_statement (annual, 2022-12-31) — Diluted EPS: 2.97
IBCP income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 63351000.00
IBCP cash_flow (annual, 2022-12-31) — End Cash Position: 74371000.00
IBCP cash_flow (annual, 2022-12-31) — Financing Cash Flow: 294858000.00
IBCP cash_flow (annual, 2022-12-31) — Free Cash Flow: 88953000.00
IBCP cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 275000.00
IBCP income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -275000.00
IBCP balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -92763000.00
IBCP income_statement (annual, 2022-12-31) — General And Administrative Expense: 84017000.00
IBCP balance_sheet (annual, 2022-12-31) — Goodwill: 28300000.00
IBCP balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 73340000.00
IBCP balance_sheet (annual, 2022-12-31) — Gross PPE: 153913000.00
IBCP balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 374818000.00
IBCP cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 10040000.00
IBCP income_statement (annual, 2022-12-31) — Insurance And Claims: 2142000.00
IBCP income_statement (annual, 2022-12-31) — Interest Expense: 19447000.00
IBCP income_statement (annual, 2022-12-31) — Interest Income: 169008000.00
IBCP cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 17657000.00
IBCP balance_sheet (annual, 2022-12-31) — Invested Capital: 512695000.00
IBCP cash_flow (annual, 2022-12-31) — Investing Cash Flow: -424592000.00
IBCP balance_sheet (annual, 2022-12-31) — Investments And Advances: 1154165000.00
IBCP cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 77000.00
IBCP cash_flow (annual, 2022-12-31) — Issuance Of Debt: 350997000.00
IBCP balance_sheet (annual, 2022-12-31) — Land And Improvements: 17435000.00
IBCP balance_sheet (annual, 2022-12-31) — Long Term Debt: 165099000.00
IBCP balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 165099000.00
IBCP cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 350997000.00
IBCP cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -295000000.00
IBCP cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -3933000.00
IBCP balance_sheet (annual, 2022-12-31) — Net Debt: 90728000.00
IBCP income_statement (annual, 2022-12-31) — Net Income: 63351000.00
IBCP income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 63351000.00
IBCP income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 63351000.00
IBCP income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 63351000.00
IBCP income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 63351000.00
IBCP cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 63351000.00
IBCP income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 63351000.00
IBCP income_statement (annual, 2022-12-31) — Net Interest Income: 149561000.00
IBCP cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 119829000.00
IBCP cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 55997000.00
IBCP cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 55997000.00
IBCP cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1930000.00
IBCP balance_sheet (annual, 2022-12-31) — Net PPE: 35893000.00
IBCP cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 1833000.00
IBCP balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 274256000.00
IBCP income_statement (annual, 2022-12-31) — Normalized Income: 63176717.15
IBCP income_statement (annual, 2022-12-31) — Occupancy And Equipment: 12914000.00
IBCP cash_flow (annual, 2022-12-31) — Operating Cash Flow: 94632000.00
IBCP cash_flow (annual, 2022-12-31) — Operating Gains Losses: -6156000.00
IBCP income_statement (annual, 2022-12-31) — Operating Revenue: 204785000.00
IBCP balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 21063971.00
IBCP balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 61000000.00
IBCP balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -92763000.00
IBCP income_statement (annual, 2022-12-31) — Other Gand A: 2871000.00
IBCP balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 45040000.00
IBCP cash_flow (annual, 2022-12-31) — Other Non Cash Items: 30680000.00
IBCP income_statement (annual, 2022-12-31) — Other Non Interest Expense: 19077000.00
IBCP balance_sheet (annual, 2022-12-31) — Other Properties: 75770000.00
IBCP balance_sheet (annual, 2022-12-31) — Other Receivables: 128904000.00
IBCP balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 779347000.00
IBCP balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 108023000.00
IBCP balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
IBCP income_statement (annual, 2022-12-31) — Pretax Income: 77788000.00
IBCP cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: -620000.00
IBCP income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 2133000.00
IBCP cash_flow (annual, 2022-12-31) — Purchase Of Investment: -140208000.00
IBCP balance_sheet (annual, 2022-12-31) — Receivables: 128904000.00
IBCP income_statement (annual, 2022-12-31) — Reconciled Depreciation: 10827000.00
IBCP cash_flow (annual, 2022-12-31) — Repayment Of Debt: -295000000.00
IBCP cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -4010000.00
IBCP balance_sheet (annual, 2022-12-31) — Retained Earnings: 119368000.00
IBCP income_statement (annual, 2022-12-31) — Salaries And Wages: 81875000.00
IBCP cash_flow (annual, 2022-12-31) — Sale Of Investment: 260037000.00
IBCP cash_flow (annual, 2022-12-31) — Sale Of PPE: 1833000.00
IBCP income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 2074000.00
IBCP income_statement (annual, 2022-12-31) — Selling General And Administration: 86091000.00
IBCP balance_sheet (annual, 2022-12-31) — Share Issued: 21063971.00
IBCP cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2143000.00
IBCP balance_sheet (annual, 2022-12-31) — Stockholders Equity: 347596000.00
IBCP balance_sheet (annual, 2022-12-31) — Tangible Book Value: 274256000.00
IBCP income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 39717.15
IBCP income_statement (annual, 2022-12-31) — Tax Provision: 14437000.00
IBCP income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
IBCP balance_sheet (annual, 2022-12-31) — Total Assets: 4999787000.00
IBCP balance_sheet (annual, 2022-12-31) — Total Capitalization: 512695000.00
IBCP balance_sheet (annual, 2022-12-31) — Total Debt: 165099000.00
IBCP balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 347596000.00
IBCP balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4652191000.00
IBCP income_statement (annual, 2022-12-31) — Total Unusual Items: 214000.00
IBCP income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 214000.00
IBCP income_statement (annual, 2023-12-31) — +Total Revenue: 200480000.00
IBCP balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -120736000.00
IBCP income_statement (annual, 2023-12-31) — Amortization: 547000.00
IBCP income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 547000.00
IBCP income_statement (annual, 2023-12-31) — Basic Average Shares: 20945745.00
IBCP income_statement (annual, 2023-12-31) — Basic EPS: 2.82
IBCP cash_flow (annual, 2023-12-31) — Beginning Cash Position: 74371000.00
IBCP balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 61190000.00
IBCP cash_flow (annual, 2023-12-31) — Capital Expenditure: -6024000.00
IBCP cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -6024000.00
IBCP balance_sheet (annual, 2023-12-31) — Capital Stock: 317483000.00
IBCP balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 169781000.00
IBCP balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 169781000.00
IBCP cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -19327000.00
IBCP balance_sheet (annual, 2023-12-31) — Cash Financial: 68208000.00
IBCP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 182766000.00
IBCP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -162945000.00
IBCP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 75589000.00
IBCP cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -3597000.00
IBCP cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3597000.00
IBCP cash_flow (annual, 2023-12-31) — Change In Receivables: -14617000.00
IBCP cash_flow (annual, 2023-12-31) — Change In Working Capital: -18214000.00
IBCP cash_flow (annual, 2023-12-31) — Changes In Cash: 95410000.00
IBCP balance_sheet (annual, 2023-12-31) — Common Stock: 317483000.00
IBCP cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -19327000.00
IBCP balance_sheet (annual, 2023-12-31) — Common Stock Equity: 404449000.00
IBCP cash_flow (annual, 2023-12-31) — Common Stock Issuance: 70000.00
IBCP cash_flow (annual, 2023-12-31) — Common Stock Payments: -5157000.00
IBCP cash_flow (annual, 2023-12-31) — Deferred Income Tax: 215000.00
IBCP cash_flow (annual, 2023-12-31) — Deferred Tax: 215000.00
IBCP cash_flow (annual, 2023-12-31) — Depreciation: 10019000.00
IBCP cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 10019000.00
IBCP income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 547000.00
IBCP cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 10019000.00
IBCP income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 547000.00
IBCP income_statement (annual, 2023-12-31) — Diluted Average Shares: 21170968.00
IBCP income_statement (annual, 2023-12-31) — Diluted EPS: 2.79
IBCP income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 59067000.00
IBCP cash_flow (annual, 2023-12-31) — End Cash Position: 169781000.00
IBCP cash_flow (annual, 2023-12-31) — Financing Cash Flow: 182766000.00
IBCP cash_flow (annual, 2023-12-31) — Free Cash Flow: 69565000.00
IBCP cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 222000.00
IBCP cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
IBCP income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -222000.00
IBCP balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -72142000.00
IBCP income_statement (annual, 2023-12-31) — General And Administrative Expense: 82921000.00
IBCP balance_sheet (annual, 2023-12-31) — Goodwill: 28300000.00
IBCP balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 72547000.00
IBCP balance_sheet (annual, 2023-12-31) — Gross PPE: 156259000.00
IBCP balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 353988000.00
IBCP cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 16100000.00
IBCP income_statement (annual, 2023-12-31) — Insurance And Claims: 3005000.00
IBCP income_statement (annual, 2023-12-31) — Interest Expense: 83348000.00
IBCP income_statement (annual, 2023-12-31) — Interest Income: 239677000.00
IBCP cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 79101000.00
IBCP balance_sheet (annual, 2023-12-31) — Invested Capital: 533713000.00
IBCP cash_flow (annual, 2023-12-31) — Investing Cash Flow: -162945000.00
IBCP balance_sheet (annual, 2023-12-31) — Investments And Advances: 1033338000.00
IBCP cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 70000.00
IBCP cash_flow (annual, 2023-12-31) — Issuance Of Debt: 135000000.00
IBCP balance_sheet (annual, 2023-12-31) — Land And Improvements: 16421000.00
IBCP balance_sheet (annual, 2023-12-31) — Long Term Debt: 129264000.00
IBCP balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 129264000.00
IBCP cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 135000000.00
IBCP cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -170980000.00
IBCP cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -5087000.00
IBCP income_statement (annual, 2023-12-31) — Net Income: 59067000.00
IBCP income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 59067000.00
IBCP income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 59067000.00
IBCP income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 59067000.00
IBCP income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 59067000.00
IBCP cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 59067000.00
IBCP income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 59067000.00
IBCP income_statement (annual, 2023-12-31) — Net Interest Income: 156329000.00
IBCP cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 143661000.00
IBCP cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -35980000.00
IBCP cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -35980000.00
IBCP cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 2818000.00
IBCP balance_sheet (annual, 2023-12-31) — Net PPE: 35523000.00
IBCP cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 1648000.00
IBCP balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 331902000.00
IBCP income_statement (annual, 2023-12-31) — Normalized Income: 59082232.55
IBCP income_statement (annual, 2023-12-31) — Occupancy And Equipment: 11664000.00
IBCP cash_flow (annual, 2023-12-31) — Operating Cash Flow: 75589000.00
IBCP cash_flow (annual, 2023-12-31) — Operating Gains Losses: -7214000.00
IBCP income_statement (annual, 2023-12-31) — Operating Revenue: 200480000.00
IBCP balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 20835633.00
IBCP balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -72142000.00
IBCP balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 44247000.00
IBCP cash_flow (annual, 2023-12-31) — Other Non Cash Items: 23277000.00
IBCP income_statement (annual, 2023-12-31) — Other Non Interest Expense: 20645000.00
IBCP balance_sheet (annual, 2023-12-31) — Other Properties: 78648000.00
IBCP balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 679350000.00
IBCP balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
IBCP income_statement (annual, 2023-12-31) — Pretax Income: 73676000.00
IBCP cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: -650000.00
IBCP income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 2208000.00
IBCP cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1740000.00
IBCP income_statement (annual, 2023-12-31) — Reconciled Depreciation: 10019000.00
IBCP cash_flow (annual, 2023-12-31) — Repayment Of Debt: -170980000.00
IBCP cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -5157000.00
IBCP balance_sheet (annual, 2023-12-31) — Retained Earnings: 159108000.00
IBCP income_statement (annual, 2023-12-31) — Salaries And Wages: 79916000.00
IBCP cash_flow (annual, 2023-12-31) — Sale Of Investment: 145401000.00
IBCP cash_flow (annual, 2023-12-31) — Sale Of PPE: 1648000.00
IBCP income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 2165000.00
IBCP income_statement (annual, 2023-12-31) — Selling General And Administration: 85086000.00
IBCP balance_sheet (annual, 2023-12-31) — Share Issued: 20835633.00
IBCP cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2229000.00
IBCP balance_sheet (annual, 2023-12-31) — Stockholders Equity: 404449000.00
IBCP balance_sheet (annual, 2023-12-31) — Tangible Book Value: 331902000.00
IBCP income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -3767.45
IBCP income_statement (annual, 2023-12-31) — Tax Provision: 14609000.00
IBCP income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.20
IBCP balance_sheet (annual, 2023-12-31) — Total Assets: 5263726000.00
IBCP balance_sheet (annual, 2023-12-31) — Total Capitalization: 533713000.00
IBCP balance_sheet (annual, 2023-12-31) — Total Debt: 129264000.00
IBCP balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 404449000.00
IBCP balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4859277000.00
IBCP income_statement (annual, 2023-12-31) — Total Unusual Items: -19000.00
IBCP income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -19000.00
IBCP balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
IBCP cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
IBCP cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
IBCP income_statement (annual, 2024-12-31) — +Total Revenue: 215802000.00
IBCP balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -123928000.00
IBCP balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -123928000.00
IBCP income_statement (annual, 2024-12-31) — Amortization: 516000.00
IBCP income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 516000.00
IBCP balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 533796000.00
IBCP balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 533796000.00
IBCP income_statement (annual, 2024-12-31) — Basic Average Shares: 20871875.00
IBCP income_statement (annual, 2024-12-31) — Basic EPS: 3.20
IBCP cash_flow (annual, 2024-12-31) — Beginning Cash Position: 169781000.00
IBCP balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 64103000.00
IBCP balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 64103000.00
IBCP cash_flow (annual, 2024-12-31) — Capital Expenditure: -7950000.00
IBCP cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -7950000.00
IBCP balance_sheet (annual, 2024-12-31) — Capital Stock: 318777000.00
IBCP balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 119882000.00
IBCP balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 119882000.00
IBCP cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -20045000.00
IBCP balance_sheet (annual, 2024-12-31) — Cash Financial: 56984000.00
IBCP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 5109000.00
IBCP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -118159000.00
IBCP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 63151000.00
IBCP cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1017000.00
IBCP cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1017000.00
IBCP cash_flow (annual, 2024-12-31) — Change In Receivables: -25187000.00
IBCP cash_flow (annual, 2024-12-31) — Change In Working Capital: -24170000.00
IBCP cash_flow (annual, 2024-12-31) — Changes In Cash: -49899000.00
IBCP balance_sheet (annual, 2024-12-31) — Common Stock: 318777000.00
IBCP cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -20045000.00
IBCP balance_sheet (annual, 2024-12-31) — Common Stock Equity: 454686000.00
IBCP cash_flow (annual, 2024-12-31) — Common Stock Issuance: 13000.00
IBCP cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 13000.00
IBCP cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
IBCP cash_flow (annual, 2024-12-31) — Deferred Income Tax: -1248000.00
IBCP cash_flow (annual, 2024-12-31) — Deferred Tax: -1248000.00
IBCP cash_flow (annual, 2024-12-31) — Depreciation: 10005000.00
IBCP cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 10005000.00
IBCP income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 516000.00
IBCP cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 10005000.00
IBCP income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 516000.00
IBCP income_statement (annual, 2024-12-31) — Diluted Average Shares: 21136076.00
IBCP income_statement (annual, 2024-12-31) — Diluted EPS: 3.16
IBCP income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 66790000.00
IBCP cash_flow (annual, 2024-12-31) — End Cash Position: 119882000.00
IBCP cash_flow (annual, 2024-12-31) — Financing Cash Flow: 5109000.00
IBCP cash_flow (annual, 2024-12-31) — Free Cash Flow: 55201000.00
IBCP cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -2257000.00
IBCP cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
IBCP income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 2257000.00
IBCP balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -69944000.00
IBCP income_statement (annual, 2024-12-31) — General And Administrative Expense: 88774000.00
IBCP balance_sheet (annual, 2024-12-31) — Goodwill: 28300000.00
IBCP balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 76584000.00
IBCP balance_sheet (annual, 2024-12-31) — Gross PPE: 161420000.00
IBCP balance_sheet (quarterly, 2024-12-31) — Gross PPE: 161420000.00
IBCP balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 339436000.00
IBCP cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 13900000.00
IBCP income_statement (annual, 2024-12-31) — Insurance And Claims: 2870000.00
IBCP income_statement (annual, 2024-12-31) — Interest Expense: 100528000.00
IBCP income_statement (annual, 2024-12-31) — Interest Income: 266776000.00
IBCP cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 103953000.00
IBCP balance_sheet (annual, 2024-12-31) — Invested Capital: 579077000.00
IBCP cash_flow (annual, 2024-12-31) — Investing Cash Flow: -118159000.00
IBCP balance_sheet (annual, 2024-12-31) — Investments And Advances: 898618000.00
IBCP cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 13000.00
IBCP cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 13000.00
IBCP cash_flow (annual, 2024-12-31) — Issuance Of Debt: 130000000.00
IBCP balance_sheet (annual, 2024-12-31) — Land And Improvements: 16329000.00
IBCP balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 16329000.00
IBCP balance_sheet (annual, 2024-12-31) — Long Term Debt: 124391000.00
IBCP balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 124391000.00
IBCP cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 130000000.00
IBCP cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -135017000.00
IBCP cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 13000.00
IBCP balance_sheet (annual, 2024-12-31) — Net Debt: 4509000.00
IBCP balance_sheet (quarterly, 2024-12-31) — Net Debt: 4509000.00
IBCP income_statement (annual, 2024-12-31) — Net Income: 66790000.00
IBCP income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 66790000.00
IBCP income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 66790000.00
IBCP income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 66790000.00
IBCP income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 66790000.00
IBCP cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 66790000.00
IBCP income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 66790000.00
IBCP income_statement (annual, 2024-12-31) — Net Interest Income: 166248000.00
IBCP cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 136917000.00
IBCP cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -5017000.00
IBCP cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -5017000.00
IBCP cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 2934000.00
IBCP balance_sheet (annual, 2024-12-31) — Net PPE: 37492000.00
IBCP cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 960000.00
IBCP balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 378102000.00
IBCP income_statement (annual, 2024-12-31) — Normalized Income: 66653276.98
IBCP income_statement (annual, 2024-12-31) — Occupancy And Equipment: 11568000.00
IBCP cash_flow (annual, 2024-12-31) — Operating Cash Flow: 63151000.00
IBCP cash_flow (annual, 2024-12-31) — Operating Gains Losses: -8836000.00
IBCP income_statement (annual, 2024-12-31) — Operating Revenue: 215802000.00
IBCP balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 20895714.00
IBCP balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -69944000.00
IBCP balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 48284000.00
IBCP cash_flow (annual, 2024-12-31) — Other Non Cash Items: 13810000.00
IBCP income_statement (annual, 2024-12-31) — Other Non Interest Expense: 22151000.00
IBCP balance_sheet (annual, 2024-12-31) — Other Properties: 80988000.00
IBCP balance_sheet (quarterly, 2024-12-31) — Other Properties: 80988000.00
IBCP balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 559182000.00
IBCP balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
IBCP income_statement (annual, 2024-12-31) — Pretax Income: 83046000.00
IBCP cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: -1051000.00
IBCP income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 2566000.00
IBCP cash_flow (annual, 2024-12-31) — Purchase Of Investment: -3628000.00
IBCP income_statement (annual, 2024-12-31) — Reconciled Depreciation: 10005000.00
IBCP cash_flow (annual, 2024-12-31) — Repayment Of Debt: -135017000.00
IBCP cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
IBCP balance_sheet (annual, 2024-12-31) — Retained Earnings: 205853000.00
IBCP income_statement (annual, 2024-12-31) — Salaries And Wages: 85904000.00
IBCP cash_flow (annual, 2024-12-31) — Sale Of Investment: 140545000.00
IBCP cash_flow (annual, 2024-12-31) — Sale Of PPE: 960000.00
IBCP income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 3058000.00
IBCP income_statement (annual, 2024-12-31) — Selling General And Administration: 91832000.00
IBCP balance_sheet (annual, 2024-12-31) — Share Issued: 20895714.00
IBCP cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2332000.00
IBCP balance_sheet (annual, 2024-12-31) — Stockholders Equity: 454686000.00
IBCP balance_sheet (annual, 2024-12-31) — Tangible Book Value: 378102000.00
IBCP income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 33276.98
IBCP income_statement (annual, 2024-12-31) — Tax Provision: 16256000.00
IBCP income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.20
IBCP balance_sheet (annual, 2024-12-31) — Total Assets: 5338104000.00
IBCP balance_sheet (annual, 2024-12-31) — Total Capitalization: 579077000.00
IBCP balance_sheet (annual, 2024-12-31) — Total Debt: 124391000.00
IBCP balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 454686000.00
IBCP balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4883418000.00
IBCP income_statement (annual, 2024-12-31) — Total Unusual Items: 170000.00
IBCP income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 170000.00
IBCP income_statement (quarterly, 2025-03-31) — +Total Revenue: 52270000.00
IBCP income_statement (quarterly, 2025-03-31) — Amortization: 122000.00
IBCP income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 122000.00
IBCP income_statement (quarterly, 2025-03-31) — Basic Average Shares: 20943094.00
IBCP income_statement (quarterly, 2025-03-31) — Basic EPS: 0.74
IBCP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 119882000.00
IBCP cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1122000.00
IBCP cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -1122000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Capital Stock: 318365000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 128145000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 128145000.00
IBCP cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -5448000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Cash Financial: 60566000.00
IBCP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -26770000.00
IBCP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 15781000.00
IBCP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 19252000.00
IBCP cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2228000.00
IBCP cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2228000.00
IBCP cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3845000.00
IBCP cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1617000.00
IBCP cash_flow (quarterly, 2025-03-31) — Changes In Cash: 8263000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Common Stock: 318365000.00
IBCP cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -5448000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 467277000.00
IBCP cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -33000.00
IBCP cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -1036000.00
IBCP cash_flow (quarterly, 2025-03-31) — Deferred Tax: -1036000.00
IBCP cash_flow (quarterly, 2025-03-31) — Depreciation: 2352000.00
IBCP cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2352000.00
IBCP income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 122000.00
IBCP cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2352000.00
IBCP income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 122000.00
IBCP income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 21150550.00
IBCP income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.74
IBCP income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 15590000.00
IBCP cash_flow (quarterly, 2025-03-31) — End Cash Position: 128145000.00
IBCP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -26770000.00
IBCP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 18130000.00
IBCP cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 330000.00
IBCP cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 94000.00
IBCP income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -330000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -67083000.00
IBCP income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 21326000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Goodwill: 28300000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 61837000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 336928000.00
IBCP cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 2500000.00
IBCP income_statement (quarterly, 2025-03-31) — Insurance And Claims: 711000.00
IBCP income_statement (quarterly, 2025-03-31) — Interest Expense: 22459000.00
IBCP income_statement (quarterly, 2025-03-31) — Interest Income: 66144000.00
IBCP cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 21576000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Invested Capital: 591709000.00
IBCP cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 15781000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 866604000.00
IBCP cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 95005000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 124432000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 124432000.00
IBCP cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 95005000.00
IBCP cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -95000000.00
IBCP cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -33000.00
IBCP income_statement (quarterly, 2025-03-31) — Net Income: 15590000.00
IBCP income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 15590000.00
IBCP income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 15590000.00
IBCP income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 15590000.00
IBCP income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 15590000.00
IBCP cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 15590000.00
IBCP income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 15590000.00
IBCP income_statement (quarterly, 2025-03-31) — Net Interest Income: 43685000.00
IBCP cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 35730000.00
IBCP cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 5000.00
IBCP cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 5000.00
IBCP cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1766000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Net PPE: 37369000.00
IBCP cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
IBCP balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 405440000.00
IBCP income_statement (quarterly, 2025-03-31) — Normalized Income: 15536202.03
IBCP income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 3108000.00
IBCP cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 19252000.00
IBCP cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1879000.00
IBCP income_statement (quarterly, 2025-03-31) — Operating Revenue: 52270000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 20970115.00
IBCP balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -67083000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 33537000.00
IBCP cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1129000.00
IBCP income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 6538000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 529676000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
IBCP income_statement (quarterly, 2025-03-31) — Pretax Income: 19126000.00
IBCP cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -1137000.00
IBCP income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 479000.00
IBCP cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1000000.00
IBCP income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2352000.00
IBCP cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -95000000.00
IBCP cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -33000.00
IBCP income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
IBCP balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 215995000.00
IBCP income_statement (quarterly, 2025-03-31) — Salaries And Wages: 20615000.00
IBCP cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 36730000.00
IBCP cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
IBCP income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 861000.00
IBCP income_statement (quarterly, 2025-03-31) — Selling General And Administration: 22187000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Share Issued: 20970115.00
IBCP income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
IBCP cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 758000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 467277000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 405440000.00
IBCP income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 12202.03
IBCP income_statement (quarterly, 2025-03-31) — Tax Provision: 3536000.00
IBCP income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.18
IBCP balance_sheet (quarterly, 2025-03-31) — Total Assets: 5328428000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 591709000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Total Debt: 124432000.00
IBCP balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 467277000.00